Long-term survival of ANCA-associated vasculitis

被引:0
|
作者
Flossmann, Oliver [1 ]
Berden, Annelies [2 ]
De Groot, Kirsten [3 ]
Harper, Lorraine [4 ]
Heijl, Caroline [5 ]
HOGlund, Peter [6 ]
Jayne, David [1 ]
Luqmani, Raashid [7 ]
Mahr, Alfred [8 ]
Mukhtyar, Chetan [7 ]
Pusey, Charles [9 ]
Rasmussen, Niels [10 ]
Westman, Kerstin [5 ]
机构
[1] Addenbrookes Hosp, Vasculitis & Lupus Unit, Cambridge, England
[2] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[3] Klinikum Offenbach GmbH, Med Klin 3, Klin Nephrol & Rheumatol, Offenbach, Germany
[4] Univ Birmingham, Div Immun & Infect, Birmingham, W Midlands, England
[5] Lund Univ, Dept Nephrol, S-22101 Lund, Sweden
[6] Lund Univ, Dept Clin Pharmacol, Lund, Sweden
[7] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[8] Hop Cochin, Serv Med Interne, F-75674 Paris, France
[9] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England
[10] Rigshosp, Dept Otolaryngol, DK-2100 Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:139 / 139
页数:1
相关论文
共 50 条
  • [1] Long-term patient survival in ANCA-associated vasculitis
    Flossmann, Oliver
    Berden, Annelies
    de Groot, Kirsten
    Hagen, Chris
    Harper, Lorraine
    Heijl, Caroline
    Hoglund, Peter
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    Mukhtyar, Chetan
    Pusey, Charles
    Rasmussen, Niels
    Stegeman, Coen
    Walsh, Michael
    Westman, Kerstin
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (03) : 488 - 494
  • [2] Long-term rituximab for ANCA-associated vasculitis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (07): : E389 - E389
  • [3] Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis
    Sanchez alamo, Beatriz
    Moi, Laura
    Bajema, Ingeborg
    Faurschou, Mikkel
    Flossmann, Oliver
    Hauser, Thomas
    Hruskova, Zdenka
    Jayne, David
    Luqmani, Raashid
    Mahr, Alfred
    akesson, Anna
    Westman, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (07) : 1655 - 1665
  • [4] The long-term prognosis of patients with ANCA-associated vasculitis with renalinvolvement
    不详
    KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (02): : 88 - 88
  • [5] Risk of malignancy with long-term immunosuppression in ANCA-associated vasculitis
    Rahmattulla, C.
    Goceroglu, A.
    Reinders, M. E. J.
    Hagen, E. C.
    Bruijn, J. A.
    Bajema, I. M.
    PRESSE MEDICALE, 2013, 42 (04): : 767 - 767
  • [6] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Nadezhda Wall
    Lorraine Harper
    Nature Reviews Nephrology, 2012, 8 : 523 - 532
  • [7] Complications of long-term therapy for ANCA-associated systemic vasculitis
    Wall, Nadezhda
    Harper, Lorraine
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (09) : 523 - 532
  • [8] Good long-term results for rituximab in ANCA-associated vasculitis
    Nature Clinical Practice Rheumatology, 2007, 3 (2): : 64 - 65
  • [9] Long-term outcomes in elderly patients with ANCA-associated vasculitis
    McGovern, Dominic
    Williams, Sam P.
    Parsons, Katrina
    Farrah, Tariq E.
    Gallacher, Peter J.
    Miller-Hodges, Eve
    Kluth, David C.
    Hunter, Robert W.
    Dhaun, Neeraj
    RHEUMATOLOGY, 2020, 59 (05) : 1076 - 1083
  • [10] Predictors of long-term (≥ 5 year) renal survival in 535 patients with ANCA-associated vasculitis
    Berden, Annelies
    Flossmann, Oliver
    Westman, Kerstin
    Hoglund, Peter
    Hagen, E. Christiaan
    le Cessie, Saskia
    Walsh, Michael
    Bruijn, Jan Anthonie
    Jayne, David
    Bajema, Ingeborg
    APMIS, 2009, 117 : 150 - 150